Industry Statistics
- Companies: 23
- Median P/E: 35.2 (vs. sector 26.6)
- Average ROE: 23.4% (vs. sector 7.0%)
- Average debt/equity: 0.81 (vs. sector 0.80)
- Average dividend yield: 0.4% (vs. sector 0.5%)
- Average net margin: 8.1% (vs. sector -0.2%)
- Total market cap: $839.2B
Cheapest by P/E
- Qiagen N.V. (QGEN) — P/E 22.9
- Quest Diagnostics Incorporated (DGX) — P/E 24.8
- Labcorp Holdings Inc. (LH) — P/E 25.5
- CareDx, Inc (CDNA) — P/E 31.2
- IQVIA Holdings Inc. (IQV) — P/E 32.0
Top Dividend Payers
- Qiagen N.V. (QGEN) — 5.9%
- Quest Diagnostics Incorporated (DGX) — 1.4%
- Labcorp Holdings Inc. (LH) — 0.9%
- Danaher Corporation (DHR) — 0.7%
- Agilent Technologies, Inc. (A) — 0.6%
Top Companies by Market Cap
- Thermo Fisher Scientific Inc. (TMO) — $242.1B · P/E 35.2
- Danaher Corporation (DHR) — $150.5B · P/E 38.0
- Natera, Inc. (NTRA) — $58.5B
- Agilent Technologies, Inc. (A) — $47.4B · P/E 33.0
- IQVIA Holdings Inc. (IQV) — $42.5B · P/E 32.0
- Waters Corporation (WAT) — $41.7B · P/E 106.0
- Illumina, Inc. (ILMN) — $41.3B · P/E 50.9
- IDEXX Laboratories, Inc. (IDXX) — $40.9B · P/E 36.7
- Quest Diagnostics Incorporated (DGX) — $25.7B · P/E 24.8
- Labcorp Holdings Inc. (LH) — $25.3B · P/E 25.5
- Guardant Health, Inc. (GH) — $23.5B
- Revvity, Inc. (RVTY) — $16.9B · P/E 72.2
- Medpace Holdings, Inc. (MEDP) — $16.7B · P/E 35.3
- Charles River Laboratories International, Inc. (CRL) — $14.0B
- ICON Public Limited Company (ICLR) — $12.4B · P/E 37.8
- Qiagen N.V. (QGEN) — $9.2B · P/E 22.9
- GRAIL Inc. (GRAL) — $5.7B
- RadNet, Inc. (RDNT) — $5.5B
- Sotera Health Company (SHC) — $5.3B · P/E 32.4
- BillionToOne, Inc. (BLLN) — $4.9B · P/E 170.8
- Veracyte, Inc. (VCYT) — $3.7B · P/E 32.7
- CareDx, Inc (CDNA) — $3.3B · P/E 31.2
- GeneDx Holdings Corp. (WGS) — $2.2B
Related industries
- Drug Manufacturers - General · 16 · $4.12T
- Biotechnology · 98 · $1.07T
- Medical - Devices · 27 · $712.3B
- Medical - Healthcare Plans · 8 · $691.4B
- Medical - Instruments & Supplies · 19 · $377.6B
- Drug Manufacturers - Specialty & Generic · 14 · $242.3B
- Medical - Distribution · 4 · $228.9B
- Medical - Care Facilities · 20 · $219.8B
- Medical - Healthcare Information Services · 8 · $57.4B
- Medical - Specialties · 2 · $51.4B
- Medical - Pharmaceuticals · 5 · $48.5B
Frequently Asked Questions
How many publicly-traded companies are in the Medical - Diagnostics & Research industry?
The Medical - Diagnostics & Research industry has 23 publicly-listed companies in the US and Canadian markets tracked by Kaplio, with a combined market capitalization of $839.2B.
What is the median P/E ratio of Medical - Diagnostics & Research stocks?
The Medical - Diagnostics & Research companies above $2 billion with consistent data trade at a median P/E of 35.2. For comparison, the median of the Healthcare sector is 26.6.
What are the largest companies in the Medical - Diagnostics & Research industry?
By market capitalization, the largest Medical - Diagnostics & Research companies tracked by Kaplio are Thermo Fisher Scientific Inc., Danaher Corporation, Natera, Inc.. The full ranking of the top 25 companies by market cap is available above.
Which Medical - Diagnostics & Research stocks have the highest dividend yield?
Top dividend payers in Medical - Diagnostics & Research include Qiagen N.V., Quest Diagnostics Incorporated, Labcorp Holdings Inc., with an industry-average dividend yield of 0.4%.
How profitable are Medical - Diagnostics & Research companies?
Companies in the Medical - Diagnostics & Research industry average a net profit margin of 8.1% and a return on equity (ROE) of 23.4%, based on 23 companies tracked. Average debt-to-equity ratio is 0.81.